{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T16:23:58Z","timestamp":1789057438913,"version":"build-2803163510"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T00:00:00Z","timestamp":1655769600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T00:00:00Z","timestamp":1655769600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100006739","name":"Capital Foundation of Medical Development","doi-asserted-by":"publisher","award":["2014-2-5122"],"award-info":[{"award-number":["2014-2-5122"]}],"id":[{"id":"10.13039\/501100006739","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s00277-022-04844-5","type":"journal-article","created":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T00:02:15Z","timestamp":1655769735000},"page":"1777-1783","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Successful desensitization of high level donor-specific anti-HLA antibody in patients with hematological diseases receiving haploidentical allografts"],"prefix":"10.1007","volume":"101","author":[{"given":"Xiaoli","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmei","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6524-6509","authenticated-orcid":false,"given":"Hengxiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,21]]},"reference":[{"issue":"8","key":"4844_CR1","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1016\/j.bbmt.2015.05.001","volume":"21","author":"SO Ciurea","year":"2015","unstructured":"Ciurea SO, Thall PF, Milton DR et al (2015) Complement-binding donor-specific anti-hla antibodies and risk of primary graft failure in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 21(8):1392\u20131398","journal-title":"Biol Blood Marrow Transplant"},{"issue":"13","key":"4844_CR2","doi-asserted-by":"publisher","first-page":"2704","DOI":"10.1182\/blood-2009-09-244525","volume":"115","author":"S Spellman","year":"2010","unstructured":"Spellman S, Bray R, Rosen-Bronson S et al (2010) The detection of donor-directed, HLA-specific alloantibodies in recipients of unrelated hematopoietic cell transplantation is predictive of graft failure. Blood 115(13):2704\u20132708","journal-title":"Blood"},{"issue":"7","key":"4844_CR3","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1016\/j.bbmt.2019.02.020","volume":"25","author":"S Bramanti","year":"2019","unstructured":"Bramanti S, Calafiore V, Longhi E et al (2019) Donor-specific anti-HLA antibodies in haploidentical stem cell transplantation with post-transplantation cyclophosphamide: risk of graft failure, poor graft function, and impact on outcomes. Biol Blood Marrow Transplant 25(7):1395\u20131406","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"4844_CR4","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/s41409-019-0712-0","volume":"55","author":"S Fuji","year":"2020","unstructured":"Fuji S, Oshima K, Ohashi K et al (2020) Impact of pretransplant donor-specific anti-HLA antibodies on cord blood transplantation on behalf of the Transplant Complications Working Group of Japan Society for Hematopoietic Cell Transplantation. Bone Marrow Transplant 55(4):722\u2013728","journal-title":"Bone Marrow Transplant"},{"key":"4844_CR5","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3389\/fimmu.2016.00307","volume":"7","author":"S Morin-Zorman","year":"2016","unstructured":"Morin-Zorman S, Loiseau P, Taupin J-L et al (2016) Donor-specific anti-HLA antibodies in allogeneic hematopoietic stem cell transplantation. Front Immunol 7:307","journal-title":"Front Immunol"},{"issue":"4","key":"4844_CR6","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.bbmt.2013.01.016","volume":"19","author":"DE Gladstone","year":"2013","unstructured":"Gladstone DE, Zachary AA, Fuchs EJ et al (2013) Partially mismatched transplantation and human leukocyte antigen donor-specific antibodies. Biol Blood Marrow Transplant 19(4):647\u2013652","journal-title":"Biol Blood Marrow Transplant"},{"key":"4844_CR7","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13045-015-0182-9","volume":"8","author":"YJ Chang","year":"2015","unstructured":"Chang YJ, Zhao XY, Xu LP et al (2015) Donor-specific anti-human leukocyte antigen antibodies were associated with primary graft failure after unmanipulated haploidentical blood and marrow transplantation: a prospective study with randomly assigned training and validation sets. J Hematol Oncol 8:84","journal-title":"J Hematol Oncol"},{"issue":"8","key":"4844_CR8","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1097\/00007890-200204270-00014","volume":"73","author":"C S\u00fcsal","year":"2002","unstructured":"S\u00fcsal C, Opelz G (2002) Kidney graft failure and presentation against HLA class I and class II antigens. Transplantation 73(8):1269\u20131273","journal-title":"Transplantation"},{"issue":"8","key":"4844_CR9","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1038\/s41409-019-0486-4","volume":"54","author":"M Minami","year":"2019","unstructured":"Minami M, Matsushima T, Mori Y et al (2019) Successful rescue transplantation with desensitization procedure after primary graft failure due to donor-specific antibody. Bone Marrow Transplant 54(8):1374\u20131376","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"4844_CR10","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1111\/trf.13523","volume":"56","author":"S Bramanti","year":"2016","unstructured":"Bramanti S, Nocco A, Mauro E et al (2016) Desensitization with plasma exchange in a patient with human leukocyte antigen donor-specific antibodies before T-cell-replete haploidentical transplantation. Transfusion 56(5):1096\u20131100","journal-title":"Transfusion"},{"issue":"3","key":"4844_CR11","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/tan.13627","volume":"94","author":"MK Misra","year":"2019","unstructured":"Misra MK, Xin JJ, Brown NK et al (2019) Effective desensitization for a strong donor-specific HLA antibody in a case of HLA-mismatched allogeneic hematopoietic cell transplantation. HLA 94(3):307\u2013311","journal-title":"HLA"},{"issue":"3","key":"4844_CR12","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1111\/bjh.12890","volume":"166","author":"RM Fasano","year":"2014","unstructured":"Fasano RM, Mamcarz E, Adams S et al (2014) Persistence of recipient human leucocyte antigen (HLA) antibodies and production of donor HLA antibodies following reduced intensity allogeneic haematopoietic stem cell transplantation. Br J Haematol 166(3):425\u2013434","journal-title":"Br J Haematol"},{"issue":"10","key":"4844_CR13","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1038\/s41409-019-0497-1","volume":"54","author":"U La Rocca","year":"2019","unstructured":"La Rocca U, Perrone MP, Piciocchi A et al (2019) Anti-HLA donor-specific antibodies in allogeneic stem cell transplantation: management and desensitization protocol. Bone Marrow Transplant 54(10):1717\u20131720","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"4844_CR14","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.jcyt.2013.04.007","volume":"15","author":"HX Wang","year":"2013","unstructured":"Wang HX, Wang ZD, Zheng XL et al (2013) Hematopoietic stem cell transplantation with umbilical cord multipotent stromal cell infusion for the treatment of aplastic anemia\u2013a single-center experience. Cytotherapy 15(9):1118\u20131125","journal-title":"Cytotherapy"},{"issue":"Suppl 2","key":"4844_CR15","doi-asserted-by":"publisher","first-page":"S58","DOI":"10.1038\/bmt.2008.56","volume":"41","author":"LM Ball","year":"2008","unstructured":"Ball LM, Egeler Rm (2008) Acute GvHD: pathogenesis and classification. Bone Marrow Transplant 41(Suppl 2):S58-64","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"4844_CR16","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/j.1365-2141.2012.09128.x","volume":"158","author":"FL Dignan","year":"2012","unstructured":"Dignan FL, Amrolia P, Clark A et al (2012) Diagnosis and management of chronic graft-versus-host disease. Br J Haematol 158(1):46\u201361","journal-title":"Br J Haematol"},{"issue":"5","key":"4844_CR17","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/s41409-017-0062-8","volume":"53","author":"SO Ciurea","year":"2018","unstructured":"Ciurea SO, Cao K, Fernadez-Vina M et al (2018) The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the detection and treatment of donor-specific anti-HLA antibodies (DSA) in haploidentical hematopoietic cell transplantation. Bone Marrow Transplant 53(5):521\u2013534","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"4844_CR18","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/imr.12150","volume":"258","author":"AA Zachary","year":"2014","unstructured":"Zachary AA, Leffell MS (2014) Desensitization for solid organ and hematopoietic stem cell transplantation. Immunol Rev 258(1):183\u2013207","journal-title":"Immunol Rev"},{"issue":"6","key":"4844_CR19","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/bmt.2014.331","volume":"50","author":"MS Leffell","year":"2015","unstructured":"Leffell MS, Jones RJ, Gladstone DE (2015) Donor HLA-specific Abs: to BMT or not to BMT? Bone Marrow Transplant 50(6):751\u2013758","journal-title":"Bone Marrow Transplant"},{"key":"4844_CR20","doi-asserted-by":"crossref","unstructured":"Zhang RL, He Y, Yang DL et al (2020) Combination treatment of rituximab and donor platelets infusion to reduce donor-specific anti-HLA anstibodies for stem cells engraftment in haploidentical transplantation. J Clin Lab Anal 34(7):e23261","DOI":"10.1002\/jcla.23261"},{"issue":"7","key":"4844_CR21","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1038\/s41409-020-0928-z","volume":"55","author":"YJ Chang","year":"2020","unstructured":"Chang YJ, Xu LP, Wang Y et al (2020) Rituximab for desensitization during HLA-mismatched stem cell transplantation in patients with a positive donor-specific anti-HLA antibody. Bone Marrow Transplant 55(7):1326\u20131336","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"4844_CR22","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.imlet.2015.06.013","volume":"168","author":"ME Bernardo","year":"2015","unstructured":"Bernardo ME, Fibbe WE (2015) Mesenchymal stromal cells and hematopoietic stem cell transplantation. Immunol Lett 168(2):215\u2013221","journal-title":"Immunol Lett"},{"issue":"2","key":"4844_CR23","doi-asserted-by":"publisher","first-page":"e60","DOI":"10.1016\/j.bbmt.2018.10.018","volume":"25","author":"H Choe","year":"2019","unstructured":"Choe H, Gergis U, Hsu J et al (2019) Bortezomib and immune globulin have limited effects on donor-specific HLA antibodies in haploidentical cord blood stem cell transplantation: detrimental effect of persistent haploidentical donor-specific HLA antibodies. Biol Blood Marrow Transplant 25(2):e60\u2013e64","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"4844_CR24","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/bmt.2011.131","volume":"47","author":"S Yoshihara","year":"2012","unstructured":"Yoshihara S, Maruya E, Taniguchi K et al (2012) Risk and prevention of graft failure in patients with preexisting donor-specific HLA antibodies undergoing unmanipulated haploidentical HCT. Bone Marrow Transplant 47(4):508\u2013515","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"4844_CR25","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.bbmt.2015.08.015","volume":"22","author":"ZJ Pan","year":"2016","unstructured":"Pan ZJ, Yuan XN, Li Y et al (2016) Dynamic detection of anti-human leukocyte antigen (HLA) antibodies but not HLA-DP loci mismatches can predict acute graft-versus-host disease and overall survival in HLA 12\/12-matched unrelated donor allogeneic hematopoietic stem cell transplantation for hematological malignancies. Biol Blood Marrow Transplant 22(1):86\u201395","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"4844_CR26","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.bbmt.2015.09.027","volume":"22","author":"F Delbos","year":"2016","unstructured":"Delbos F, Barhoumi W, Cabanne L et al (2016) Donor immunization against human leukocyte class II antigens is a risk factor for graft-versus-host disease. Biol Blood Marrow Transplant 22(2):292\u2013329","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-022-04844-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-022-04844-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-022-04844-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T13:09:22Z","timestamp":1657717762000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-022-04844-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,21]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["4844"],"URL":"https:\/\/doi.org\/10.1007\/s00277-022-04844-5","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,21]]},"assertion":[{"value":"6 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}